Nadav brings 23 years of global, multi-segment general management experience in Medtech.

Nadav is the CEO of Cynosure an energy based aesthetics device maker and lead the acquisition and merger with Lutronic announced in January, 2024.

Prior to Cynosure Nadav was with Johnson & Johnson for 22 years where he last served as Global President, Spine for DePuy Synthes Companies. Additional roles at J&J include Vice President, for in the Diabetes Care franchise, including commercial activity for LifeScan and Animas subsidiaries as well as Vice President, Sales & Marketing, for the cardiovascular franchise including Cordis & Biosense Webster.

Nadav serves as a director for a Revival portfolio company, Augmedics, and leads Revival’s Israeli relations and strategy.